You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR HYDROCORTISONE BUTYRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for hydrocortisone butyrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00693693 ↗ Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis Completed Wake Forest University Phase 4 2006-11-01 The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.
NCT01797562 ↗ Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Unknown status Allerderm Phase 4 2012-12-01 To evaluate the performance and safety of seven T.R.U.E. Test Panel allergens in subjects 6-17 years of age with suspected contact dermatitis.
NCT02959580 ↗ Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis Unknown status Peking Union Medical College Hospital Phase 4 2017-01-01 This study evaluates the clinical response rate of topical steroids in the treatment of idiopathic granulomatous mastitis in female adults. Half of the participants will receive topical steroid and the other half will receive local wide surgical excision.
NCT03539601 ↗ A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD Terminated Pfizer Phase 4 2018-04-27 This 4-week study will evaluate the safety and efficacy of crisaborole ointment 2%; crisaborole vehicle; topical corticosteroid and topical calcineurin inhibitor, applied twice daily (BID) in subjects who are at least 2 years of age with mild-moderate AD. A Sub-Study of Optical Coherence Tomography and Biomarkers in Subjects ages 2 to <18 years old, with Mild to Moderate Atopic Dermatitis, treated with Crisaborole Ointment, 2% or Crisaborole Vehicle Ointment or Hydrocortisone Butyrate 0.1% Cream applied BID will also be conducted at select sites.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for hydrocortisone butyrate

Condition Name

Condition Name for hydrocortisone butyrate
Intervention Trials
Atopic Dermatitis 2
Allergic Contact Dermatitis 1
Granulomatous Mastitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for hydrocortisone butyrate
Intervention Trials
Dermatitis 3
Eczema 2
Dermatitis, Atopic 2
Mastitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for hydrocortisone butyrate

Trials by Country

Trials by Country for hydrocortisone butyrate
Location Trials
United States 13
Germany 5
Italy 4
United Kingdom 2
Poland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for hydrocortisone butyrate
Location Trials
Kentucky 2
California 2
North Carolina 2
Texas 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for hydrocortisone butyrate

Clinical Trial Phase

Clinical Trial Phase for hydrocortisone butyrate
Clinical Trial Phase Trials
Phase 4 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for hydrocortisone butyrate
Clinical Trial Phase Trials
Unknown status 2
Completed 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for hydrocortisone butyrate

Sponsor Name

Sponsor Name for hydrocortisone butyrate
Sponsor Trials
Wake Forest University 1
Allerderm 1
Peking Union Medical College Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for hydrocortisone butyrate
Sponsor Trials
Other 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.